Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4393
Title: Regenerative matching axial vascularisation of absorbable 3D-printed scaffold for large bone defects: A first in human series
Authors: Wagels, Michael 
Castrisos, George
Gonzalez Matheus, Isabel
Sparks, David
Lowe, Martin
Ward, Nicola
Sehu, Marjoree
Wille, Marie-Luise
Phua, Yun
Medeiros Savi, Flavia
Hutmacher, Dietmar
Issue Date: 2022
Source: 75, (7), 2022, p. 2108-2118
Pages: 2108-2118
Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS
Abstract: Background: We describe the first clinical series of a novel bone replacement technique based on regenerative matching axial vascularisation (RMAV). This was used in four cases: a tibial defect after treatment of osteomyelitis; a calvarial defect after trauma and failed titanium cranioplasty; a paediatric tibial defect after neoadjuvant chemotherapy and resection of Ewing sarcoma; and a paediatric mandibular deficiency resulting from congenital hemifacial microsomia.; Method: All patients underwent reconstruction with three-dimensional (3D)-printed medical-grade polycaprolactone and tricalcium phosphate (mPCL-TCP) scaffolds wrapped in vascularised free corticoperiosteal flaps.; Outcome: Functional volumes of load-sharing regenerate bone have formed in all cases after a moderate duration of follow-up. At 36 cm, case 1 remains the longest segment of load bearing bone ever successfully reconstructed. This technique offers an alternative to existing methods of large volume bone defect reconstruction that may be safe, reliable, and give predictable outcomes in challenging situations. It achieves this by using a bioresorbable scaffold to support and direct the growth of regenerate bone, driven by RMAV.; Conclusion: This technique may facilitate the reconstruction of bone defects previously thought unreconstructable, reduce the risk of long-term implant-related complications and achieve these outcomes in a hostile environment. These potential benefits must now be formally tested in prospective clinical trials. (Crown Copyright © 2022. Published by Elsevier Ltd. All rights reserved.)Date of Electronic Publication: 2022 Mar 09. ; Original Imprints: Publication: Amsterdam, The Netherlands : Elsevier, c2006-
DOI: 10.1016/j.bjps.2022.02.057
Resources: https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,athens&db=mdc&AN=35370116&site=ehost-live
Keywords: Prospective Studies;Printing, Three-Dimensional*Tissue Scaffolds*;Child;Humans;Skull
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

44
checked on Feb 12, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.